(Q53146225)
Statements
Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: results from the adalimumab trial evaluating long-term safety and efficacy for ankylosing spondylitis (ATLAS). (English)
Dennis A Revicki
Michelle P Luo
Paul Wordsworth
Robert L Wong
Naijun Chen
John C Davis
ATLAS Study Group
15 May 2008
35
7
1346-1353